色噜噜人体337p人体 I 超碰97观看 I 91久久香蕉国产日韩欧美9色 I 色婷婷我要去我去也 I 日本午夜a I 国产av高清怡春院 I 桃色精品 I 91香蕉国产 I 另类小说第一页 I 日操夜夜操 I 久久性色 I 日韩欧在线 I 国产深夜在线观看 I 免费的av I 18在线观看视频 I 他也色在线视频 I 亚洲熟女中文字幕男人总站 I 亚洲国产综合精品中文第一 I 人妻丰满熟av无码区hd I 新黄色网址 I 国产精品真实灌醉女在线播放 I 欧美巨大荫蒂茸毛毛人妖 I 国产一区欧美 I 欧洲亚洲1卡二卡三卡2021 I 国产亚洲欧美在线观看三区 I 97精品无人区乱码在线观看 I 欧美妇人 I 96精品在线视频 I 国产人免费视频在线观看 I 91麻豆国产福利在线观看

雅思閱讀模擬試題參考

時間:2021-06-10 19:14:49 試題 我要投稿

雅思閱讀模擬試題參考

  1. The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels. But many researchers remain confident that drugs to boost levels of ’good’ cholesterol are still one of the most promising means to combat spiralling heart disease.

雅思閱讀模擬試題參考

  2. Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib, a drug designed to raise heart-protective high-density lipoproteins (HDLs)。 In a trial of 15000 patients, a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone.

  3. The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease. There have been no red flags to my knowledge, says John Chapman, a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib. This cancellation came as a complete shock.

  4. Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs, which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body. Specifically, torcetrapib blocks a protein called cholesterol ester transfer protein (CETP), which normally transfers the cholesterol from high-density lipoproteins to low density, plaque-promoting ones. Statins, in contrast, mainly work by lowering the ’bad’ low-density lipoproteins.

  Under pressure

  5. Researchers are now trying to work out why and how the drug backfired, something that will not become clear until the clinical details are released by Pfizer. One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients. It was thought that this mild problem would be offset by the heart benefits of the drug. But it is possible that it actually proved fatal in some patients who already suffered high blood pressure. If blood pressure is the explanation, it would actually be good news for drug developers because it suggests that the problems are specific to this compound. Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall.

  6. But it is also possible that the whole idea of blocking CETP is flawed, says Moti Kashyap, who directs atherosclerosis research at the VA Medical Center in Long Beach, California. When HDLs excrete cholesterol in the liver, they actually rely on LDLs for part of this process. So inhibiting CETP, which prevents the transfer of cholesterol from HDL to LDL, might actually cause an abnormal and irreversible accumulation of cholesterol in the body. You’re blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway, says Kashyap.

  Going up

  7. Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients. But HDLs are complex and not entirely understood. One approved drug, called niacin, is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling. Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone. Scientists are also working on several other means to bump up high-density lipoproteins by, for example, introducing synthetic HDLs. The only thing we know is dead in the water is torcetrapib, not the whole idea of raising HDL, says Michael Miller, director of preventive cardiology at the University of Maryland Medical Center, Baltimore.

  (613 words nature)

  Questions 1-7

  This passage has 7 paragraphs 1-7.

  Choose the correct heading for each paragraph from the list of headings below.

  Write the correct number i-ix in boxes 1-7 on your answer sheet.

  List of Headings

  i. How does torcetrapib work?

  ii. Contradictory result prior to the current trial

  iii. One failure may possibly bring about future success

  iv. The failure doesn’t lead to total loss of confidence

  v. It is the right route to follow

  vi. Why it’s stopped

  vii. They may combine and theoretically produce ideal result

  viii. What’s wrong with the drug

  ix. It might be wrong at the first place

  Example answer

  Paragraph 1 iv

  1. Paragraph 2

  2. Paragraph 3

  3. Paragraph 4

  4. Paragraph 5

  5. Paragraph 6

  6. Paragraph 7

  Questions 7-13

  Match torcetrapib,HDLs,statin and CETP with their functions (Questions 8-13)。。

  Write the correct letter A, B, C or D in boxes 8-13 on your answer sheet.

  NB You may use any letter more than once.

  7.It has been administered to over 10,000 subjects in a clinical trial.

  8.It could help rid human body of cholesterol.

  9.Researchers are yet to find more about it.

  10. It was used to reduce the level of cholesterol.

  11. According to Kashyap, it might lead to unwanted result if it’s blocked.

  12. It produced contradictory results in different trials.

  13. It could inhibit LDLs.

  List of choices

  A. Torcetrapic

  B. HDLS

  C. Statin

  D. CETP

  (by Zhou Hong)

  Suggested Answers and Explanations

  1. vi

  2. ii

  3. vii 本段介紹了torcetrapib和statin的治病原理,但是同時短語in contrast與之前第二段后半段的內容呼應,暗示了這兩種藥在理論上能相輔相成,是理想的搭配。第一個選項無法涵蓋整段意義,故選擇i是錯誤的。

  4. iii 本段分析了可能導致torcetrapibl臨床試驗失敗的原因,后半段指出如果以上推測正確,那么未來的藥物可借鑒這個試驗,設法避免torcetrapib的缺陷,研制出有效的'藥物。viii選項無法涵蓋后半段的意思。

  5. ix 見首句。

  6. v

  7. A 見第二段。題目中administer一詞意為用藥,subject一詞為實驗對象之意。

  8. B 見第四段… to raise levels of HDLs, which ferry cholesterol out of artery- clogging plaques to the liver for removal from the body.即HDLs的作用最終是將 choleserol清除出人體:… for removal from the body。

  9. B 見第四段But HDLs are complex and not entirely understood.

  10. C 見第二段… plus a cholesterol-lowering statin,即statin是可以降低cholesterol的。

  11. D 見第六段 So inhibiting CETP, … might actually cause an abnormal and irreversible accumulation of cholesterol in the body.

  12. A 見第三段。

  13. C 見第四段Statins, in contrast, mainly work by lowering the ’bad’ low-density lipoproteins.

【雅思閱讀模擬試題參考】相關文章:

雅思歷年閱讀模擬試題04-01

雅思閱讀模擬練習試題及答案11-26

雅思模擬閱讀習題06-14

雅思聽力模擬試題練習03-19

科學模擬試題參考06-11

模擬試題及答案參考06-13

雅思閱讀模擬練習題06-14

雅思閱讀經典模擬題06-13

關于雅思閱讀模擬習題及答案12-27

主站蜘蛛池模板: 日韩中文字幕在线一区二区 | 国语对白在线观看 | 久久综合九色综合97欧美 | 国产精品无码免费视频二三区 | 夜间福利视频 | 色老大综合 | 国产字幕av | 国产精品青草久久久久婷婷 | 国产真人无码作爱免费视频app | 伦人伦xxxx精彩对白 | 亚洲aⅴ网站 | 91视频在线观看视频 | 日日噜噜噜夜夜爽爽 | 国产女主播白浆在线看 | 一道本在线观看 | 亚洲乱码伦av | 亚洲精品国产av成拍色拍个 | 2021最新久久久视精品爱 | 涩涩av在线 | 成年人性生活免费视频 | 狠狠色综合网久久久久久 | 免费观看一区二区三区视频 | 欧美大屁股bbbbxxxx | 午夜亚洲乱码伦小说区69堂 | 99re6在线视频精品免费 | 日本高清www午色夜com | 亚洲中文字幕无码天然素人 | 永久毛片全免费福利网站 | 小泽玛利亚一区二区三区视频 | 西西人体大胆啪啪实拍 | 精品人妻av区波多野结衣 | 91久久精品国产91性色tv | 久久欧美日韩精品一区二区 | 午夜一二三 | 高清国产av一区二区三区 | 精产国品一二三产品蜜桃 | 亚洲成人福利在线 | 久久精品国内一区二区三区 | 天天摸夜夜添狠狠添婷婷 | 中字幕久久久人妻熟女 | 天堂久久久久久 | 久色激情 | 在线视频精品一区 | 欧美成人黄色影院 | 久久亚洲色一区二区三区 | 亚洲天堂一区二区在线观看 | 中文字幕一精品亚洲无线一区 | 欧美 日韩 国产 成人 在线 91 | 一区二区视频播放 | 色污视频在线观看 | 中文原创av | 厨房玩丰满人妻hd完整版视频 | 成人免费视频播放器 | 91在线入口 | 国色天香一卡2卡三卡4卡乱码 | 特黄特色特刺激视频免费播放 | 成人免费无遮挡无码黄漫视频 | 欧美日韩网址 | 91超碰国产在线 | 亚洲精品视频国产 | 一本色道久久综合 | 国产精品对白清晰受不了 | 久久久蜜桃| 涩涩在线免费观看 | y1111111丰满少妇毛片18近 | 国产成人乱色视频网站 | 欧美视频不卡 | 国产传媒一区 | 最大胆裸体人体牲交免费 | 狠狠色噜噜狠狠狠狠奇米777 | 国产综合中文字幕 | 正在播放国产真实露脸高清 | 色网站免费 | 亚洲免费av网站 | 国产午夜精品一区二区三区嫩草 | 精品日本一区二区三区在线观看 | 中国凸偷窥xxxx自由视频妇科 | 国产有码在线 | 午夜三级a三级三点窝 | 国产啪精品视频网站免 | www91视频com| 好吊妞无缓冲视频观看 | 国产精品久免费的黄牛仔短裤 | 牛牛av人人夜夜澡人人爽 | 日韩欧美黄色网址 | 亚洲国产成人无码精品 | 欧美精品毛片久久久久久久 | www.国产在线视频 | 免费啊v在线观看 | 国产成人精品视频免费看 | 国产视频1区 | 成年视频免费高清在线看 | 欧美日韩黄色一级片 | av新网址| 免费爱爱网站 | 欧美日韩福利片 | 国产美女在线精品免费观看网址 | 毛片一级黄片 | 日韩va欧美|